Smith & Nephew drops guidance as surgical procedures stop amid pandemic

Underlying revenue growth in the quarter to March is expected to drop 8% on 2019

Smith & Nephew

Smith & Nephew PLC (LON:SN.) has withdrawn guidance for 2020 as surgical procedures in the US and Europe are coming to a halt.

In China, which contributed more than half of group organic growth last year, hospital activity had restarted but remains “considerably below” pre-outbreak levels. 

READ: Analysts mull Smith & Nephew's big coronavirus assumptions

The medical products manufacturer said underlying revenue growth in the quarter to March is expected to drop 8% on 2019.

Second quarter revenue and first-half trading margin are estimated to come in “substantially down” compared to last year.

As of 31 December, net debt was US$1.6bn, with committed facilities of US$2.9bn plus another US$550mln in senior notes to be drawn in June.

Shares dropped 3% to 1,389.5p on Monday morning.

--Adds shares--

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Thor Explorations fully financed through to first gold at its flagship...

Thor Explorations Ltd's (CVE:THX) Segun Lawson updates Proactive's Andrew Scott on developments at its Segilola gold project in Nigeria. He says the majority of the financing's come from the Africa Finance Corporation - including senior debt, equity and a prepayment on a portion of the gold....

1 hour, 22 minutes ago

2 min read